Patients with histologically or cytologically proven stage III (inoperable) and IV PDAC were eligible for the trial. Previous chemotherapy for advanced disease was permitted. If gemcitabine treatment had been given previously, the patient must have tolerated a dose of at least 800?mg?m-2. Patients were required to have radiologically assessable disease and tissue that was accessible to biopsy.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Ceyhan
Contact Ceyhan, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack